Literature DB >> 18763311

Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease.

Zhou-wen Chen1, Li-ying Chen, Hong-lei Dai, Jian-hua Chen, Li-zheng Fang.   

Abstract

OBJECTIVE: To investigate the relationship between alanine aminotransferase (ALT) levels and metabolic syndrome (MS) in nonalcoholic fatty liver disease (NAFLD).
METHODS: A total of 26527 subjects who received medical health checkup in our hospital from January 2005 to July 2007 were enrolled in the study. The diagnosis of fatty liver was based on ultrasound imaging. MS was defined according to the criteria of the Adult Treatment Panel III. ALT, triglyceride (TG), high density lipoprotein cholesterol (HDL-c), fasting plasma glucose (FPG), height, weight, waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured in each subject to analyze the relationship between MS and ALT activity.
RESULTS: (1) The prevalence of NAFLD in men (30.94%) was significantly higher than that in women (15.65%); (2) The incidence of MS in NAFLD (33.83%) was significantly greater than that in non-NAFLD (10.62%); (3) Of the 6470 subjects with NAFLD, in the age-adjusted partial correlation analysis, there were statistically significant correlations between the ALT levels and most metabolic risk factors in each sex (P<0.01), except that ALT levels had no correlation with HDL-c in women. Moreover, in the multiple stepwise regression analysis, SBP lost its significance, and WC, body mass index (BMI), age, DBP, TG and FPG were independently associated with ALT levels in both sexes (P<0.05). HDL-c remained significant and was independently related to ALT levels in men; (4) ALT levels were significantly higher in subjects with MS compared to those without MS (P<0.001). Mean ALT levels increased with the number of MS components in each sex (P<0.05 for trend).
CONCLUSION: We found a strong relationship between ALT levels and MS in NAFLD and revealed that the cluster of MS components might be the predictor for ALT elevations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18763311      PMCID: PMC2491691          DOI: 10.1631/jzus.B0720016

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  34 in total

1.  [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases].

Authors: 
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2006-03

Review 2.  Non-alcoholic steatohepatitis and metabolic syndrome.

Authors:  Mariana Machado; Helena Cortez-Pinto
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-09       Impact factor: 4.294

3.  Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.

Authors:  Shira Zelber-Sagi; Dorit Nitzan-Kaluski; Zamir Halpern; Ran Oren
Journal:  Liver Int       Date:  2006-09       Impact factor: 5.828

Review 4.  Nonalcoholic steatohepatitis: pathologic features and differential diagnosis.

Authors:  Elizabeth M Brunt
Journal:  Semin Diagn Pathol       Date:  2005-11       Impact factor: 3.464

Review 5.  Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease.

Authors:  Roger K Schindhelm; Michaela Diamant; Jacqueline M Dekker; Maarten E Tushuizen; Tom Teerlink; Robert J Heine
Journal:  Diabetes Metab Res Rev       Date:  2006 Nov-Dec       Impact factor: 4.876

6.  The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease.

Authors:  Se-Yong Oh; Yong-Kyun Cho; Mun-Su Kang; Tae-Woo Yoo; Jung-Ho Park; Hong-Joo Kim; Dong-Il Park; Chong-Il Sohn; Woo-Kyu Jeon; Byung-Ik Kim; Byung-Ho Son; Jun-Ho Shin
Journal:  Metabolism       Date:  2006-12       Impact factor: 8.694

7.  The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women.

Authors:  Janani Arun; Ronald H Clements; Audrey J Lazenby; Ruth R Leeth; Gary A Abrams
Journal:  Obes Surg       Date:  2006-10       Impact factor: 4.129

8.  Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

Authors:  Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

Review 9.  The epidemiology of nonalcoholic fatty liver disease in adults.

Authors:  Jeanne M Clark
Journal:  J Clin Gastroenterol       Date:  2006-03       Impact factor: 3.062

Review 10.  Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies.

Authors:  Jian-Gao Fan; Yong-De Peng
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-12
View more
  36 in total

1.  Relationship Between Elevated Hair Mercury Levels, Essential Element Status, and Metabolic Profile in Overweight and Obese Adults.

Authors:  Anatoly V Skalny; Jung-Su Chang; Igor P Bobrovnitsky; Philippe Yu Kopylov; Margarita G Skalnaya; Shih-Yi Huang; Monica Maria Bastos Paoliello; Ekaterina S Ivanova; Weu Wang; Alexey A Tinkov
Journal:  Biol Trace Elem Res       Date:  2020-10-16       Impact factor: 3.738

2.  Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease.

Authors:  Alita Mishra; Zobair M Younossi
Journal:  J Clin Exp Hepatol       Date:  2012-07-21

3.  Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis.

Authors:  Melissa M Heintz; Ramiya Kumar; Meredith M Rutledge; William S Baldwin
Journal:  J Nutr Biochem       Date:  2019-05-21       Impact factor: 6.048

4.  Determination of the upper cut-off values of serum alanine aminotransferase and aspartate aminotransferase in Chinese.

Authors:  Peng Zhang; Chun-Yan Wang; Yu-Xiang Li; Yu Pan; Jun-Qi Niu; Shu-Mei He
Journal:  World J Gastroenterol       Date:  2015-02-28       Impact factor: 5.742

Review 5.  New insights into genetic predisposition and novel therapeutic targets for nonalcoholic fatty liver disease.

Authors:  Mary Barbara; Andrea Scott; Naim Alkhouri
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

6.  Serum levels of alanine aminotransferase decrease with age in longitudinal analysis.

Authors:  Mamie H Dong; Ricki Bettencourt; David A Brenner; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2011-10-20       Impact factor: 11.382

7.  Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease.

Authors:  Chan Wah-Kheong; Goh Khean-Lee
Journal:  Hepatol Int       Date:  2012-06-15       Impact factor: 6.047

8.  Alanine aminotransferase decreases with age: the Rancho Bernardo Study.

Authors:  Mamie H Dong; Ricki Bettencourt; Elizabeth Barrett-Connor; Rohit Loomba
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

9.  Prevalence and features of fatty liver detected by physical examination in Guangzhou.

Authors:  Xian-Hua Liao; Xu Cao; Jie Liu; Xiao-Hua Xie; Yan-Hong Sun; Bi-Hui Zhong
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

Review 10.  Hepatic fatty acid trafficking: multiple forks in the road.

Authors:  Douglas G Mashek
Journal:  Adv Nutr       Date:  2013-11-06       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.